Ligand Pharmaceuticals Incorporated (LGND) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Ligand Pharmaceuticals Incorporated LGND 295.54 −0.99%
- Mirum Pharmaceuticals, Inc. MIRM 80.18 −2.68%
Ligand Pharmaceuticals Incorporated and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated is the larger, with a market value of $6.0B against $5.4B — 1.1× the size. Mirum Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 54.9% against 44.0%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −139.2%) and the higher return on invested capital (8.19% vs −173.0%). Across the 16 metrics below, Ligand Pharmaceuticals Incorporated leads on 12 and Mirum Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | LGND | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.43% | 81.72% | 65.16% |
| Operating margin | 32.61% | (134.93%) | 0.00% |
| Net margin | 67.88% | (139.18%) | 0.00% |
| Free cash flow margin | 49.34% | (44.29%) | 0.00% |
| Return on equity | 21.96% | (702.97%) | (56.36%) |
| Return on assets | 12.58% | (97.15%) | (48.04%) |
| Return on invested capital | 8.19% | (172.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack